Datasets:
registry_id stringlengths 17 17 | year int64 2.01k 2.02k | age int64 0 94 | age_group stringclasses 8
values | sex stringclasses 2
values | cancer_type stringclasses 15
values | morphology stringclasses 7
values | grade stringclasses 5
values | basis_of_diagnosis stringclasses 4
values | vital_status stringclasses 3
values | survival_months float64 0 340 | scenario stringclasses 3
values |
|---|---|---|---|---|---|---|---|---|---|---|---|
TZ-DAR-2009-00001 | 2,009 | 49 | 45-54 | Male | Other | Lymphoma | Grade II | Microscopy | Dead | 24.2 | high_burden |
TZ-DAR-2012-00002 | 2,012 | 78 | 75+ | Female | Thyroid | Squamous cell carcinoma | Grade IV | Clinical only | Dead | 6.5 | high_burden |
TZ-DAR-2017-00003 | 2,017 | 46 | 45-54 | Male | Prostate | Other | Grade II | Imaging + clinical | Dead | 14.6 | high_burden |
TZ-DAR-2016-00004 | 2,016 | 37 | 35-44 | Female | Cervix uteri | Other | Grade III | Microscopy | Alive | 6.6 | high_burden |
TZ-DAR-2016-00005 | 2,016 | 36 | 35-44 | Female | Other | Sarcoma (incl KS) | Grade III | Microscopy | Dead | 11.1 | high_burden |
TZ-DAR-2015-00006 | 2,015 | 63 | 55-64 | Male | Other | Squamous cell carcinoma | Grade II | Microscopy | Alive | 7.1 | high_burden |
TZ-DAR-2015-00007 | 2,015 | 36 | 35-44 | Female | Other | Adenocarcinoma | Grade III | Microscopy | Alive | 25.5 | high_burden |
TZ-DAR-2010-00008 | 2,010 | 19 | 15-24 | Male | Hodgkin lymphoma | Sarcoma (incl KS) | Grade IV | Imaging + clinical | Alive | 24.2 | high_burden |
TZ-DAR-2018-00009 | 2,018 | 31 | 25-34 | Male | Other | Adenocarcinoma | Grade III | Microscopy | Alive | 10 | high_burden |
TZ-DAR-2017-00010 | 2,017 | 38 | 35-44 | Female | Other | Sarcoma (incl KS) | Grade II | Microscopy | Dead | 2.4 | high_burden |
TZ-DAR-2015-00011 | 2,015 | 43 | 35-44 | Male | Kaposi sarcoma | Adenocarcinoma | Grade II | Microscopy | Dead | 30 | high_burden |
TZ-DAR-2017-00012 | 2,017 | 35 | 35-44 | Female | Breast | Adenocarcinoma | Grade II | Microscopy | Alive | 24.5 | high_burden |
TZ-DAR-2017-00013 | 2,017 | 65 | 65-74 | Female | Other | Sarcoma (incl KS) | Grade II | Microscopy | Alive | 29.7 | high_burden |
TZ-DAR-2015-00014 | 2,015 | 36 | 35-44 | Female | Other | Adenocarcinoma | Grade II | Clinical only | Alive | 6 | high_burden |
TZ-DAR-2014-00015 | 2,014 | 39 | 35-44 | Female | Breast | Adenocarcinoma | Grade II | Microscopy | Alive | 33.4 | high_burden |
TZ-DAR-2008-00016 | 2,008 | 63 | 55-64 | Female | Breast | Squamous cell carcinoma | Grade II | Microscopy | Dead | 25 | high_burden |
TZ-DAR-2008-00017 | 2,008 | 38 | 35-44 | Female | Other | Lymphoma | Grade IV | DCO | Dead | 30.5 | high_burden |
TZ-DAR-2013-00018 | 2,013 | 36 | 35-44 | Male | Prostate | Sarcoma (incl KS) | Unknown | Microscopy | Alive | 29.9 | high_burden |
TZ-DAR-2017-00019 | 2,017 | 28 | 25-34 | Female | Cervix uteri | Adenocarcinoma | Grade I | DCO | Dead | 8.4 | high_burden |
TZ-DAR-2013-00020 | 2,013 | 40 | 35-44 | Male | Other | Lymphoma | Grade III | Microscopy | Alive | 56.8 | high_burden |
TZ-DAR-2008-00021 | 2,008 | 57 | 55-64 | Female | Cervix uteri | Sarcoma (incl KS) | Grade I | Imaging + clinical | Alive | 20.6 | high_burden |
TZ-DAR-2009-00022 | 2,009 | 60 | 55-64 | Female | Other | Adenocarcinoma | Grade II | Imaging + clinical | Alive | 1.1 | high_burden |
TZ-DAR-2011-00023 | 2,011 | 37 | 35-44 | Female | Cervix uteri | Adenocarcinoma | Grade II | Microscopy | Alive | 17.8 | high_burden |
TZ-DAR-2010-00024 | 2,010 | 68 | 65-74 | Male | Liver | Squamous cell carcinoma | Grade II | Imaging + clinical | Dead | 3 | high_burden |
TZ-DAR-2009-00025 | 2,009 | 29 | 25-34 | Male | Kaposi sarcoma | Squamous cell carcinoma | Grade IV | Microscopy | Alive | 6.2 | high_burden |
TZ-DAR-2013-00026 | 2,013 | 22 | 15-24 | Male | Leukemia | Non-keratinizing | Grade II | Microscopy | Dead | 5.8 | high_burden |
TZ-DAR-2017-00027 | 2,017 | 50 | 45-54 | Male | Non-Hodgkin lymphoma | Sarcoma (incl KS) | Grade II | Clinical only | Lost | 9.8 | high_burden |
TZ-DAR-2016-00028 | 2,016 | 27 | 25-34 | Female | Breast | Squamous cell carcinoma | Grade III | Microscopy | Alive | 15.9 | high_burden |
TZ-DAR-2014-00029 | 2,014 | 65 | 65-74 | Female | Cervix uteri | Non-keratinizing | Grade II | Microscopy | Alive | 4.7 | high_burden |
TZ-DAR-2017-00030 | 2,017 | 45 | 45-54 | Male | Kaposi sarcoma | Adenocarcinoma | Grade IV | Clinical only | Alive | 11 | high_burden |
TZ-DAR-2014-00031 | 2,014 | 58 | 55-64 | Female | Breast | Other | Grade III | Microscopy | Dead | 29.1 | high_burden |
TZ-DAR-2017-00032 | 2,017 | 39 | 35-44 | Male | Leukemia | Squamous cell carcinoma | Grade II | Microscopy | Dead | 9 | high_burden |
TZ-DAR-2016-00033 | 2,016 | 37 | 35-44 | Female | Cervix uteri | Sarcoma (incl KS) | Grade III | Microscopy | Alive | 9 | high_burden |
TZ-DAR-2010-00034 | 2,010 | 21 | 15-24 | Female | Ovary | Squamous cell carcinoma | Grade III | DCO | Lost | 0.9 | high_burden |
TZ-DAR-2018-00035 | 2,018 | 70 | 65-74 | Female | Other | Sarcoma (incl KS) | Grade II | Microscopy | Dead | 16.3 | high_burden |
TZ-DAR-2011-00036 | 2,011 | 29 | 25-34 | Female | Breast | Non-keratinizing | Grade III | Imaging + clinical | Alive | 9.8 | high_burden |
TZ-DAR-2015-00037 | 2,015 | 73 | 65-74 | Female | Cervix uteri | Sarcoma (incl KS) | Grade II | Microscopy | Lost | 6.6 | high_burden |
TZ-DAR-2013-00038 | 2,013 | 39 | 35-44 | Female | Breast | Adenocarcinoma | Unknown | Microscopy | Alive | 27.4 | high_burden |
TZ-DAR-2018-00039 | 2,018 | 4 | 0-14 | Female | Breast | Squamous cell carcinoma | Unknown | Microscopy | Lost | 10.4 | high_burden |
TZ-DAR-2012-00040 | 2,012 | 65 | 65-74 | Female | Other | Squamous cell carcinoma | Grade IV | Microscopy | Alive | 0.7 | high_burden |
TZ-DAR-2012-00041 | 2,012 | 28 | 25-34 | Female | Cervix uteri | Sarcoma (incl KS) | Grade III | Imaging + clinical | Alive | 8.2 | high_burden |
TZ-DAR-2011-00042 | 2,011 | 53 | 45-54 | Female | Breast | Sarcoma (incl KS) | Grade III | Imaging + clinical | Alive | 1.6 | high_burden |
TZ-DAR-2013-00043 | 2,013 | 61 | 55-64 | Male | Non-Hodgkin lymphoma | Squamous cell carcinoma | Grade III | Clinical only | Dead | 36.8 | high_burden |
TZ-DAR-2016-00044 | 2,016 | 38 | 35-44 | Female | Thyroid | Other | Grade III | Microscopy | Dead | 6.6 | high_burden |
TZ-DAR-2011-00045 | 2,011 | 56 | 55-64 | Female | Other | Squamous cell carcinoma | Grade I | Microscopy | Alive | 6.5 | high_burden |
TZ-DAR-2017-00046 | 2,017 | 37 | 35-44 | Male | Other | Non-keratinizing | Grade II | Imaging + clinical | Alive | 120.1 | high_burden |
TZ-DAR-2012-00047 | 2,012 | 73 | 65-74 | Male | Kaposi sarcoma | Lymphoma | Unknown | Clinical only | Alive | 120.8 | high_burden |
TZ-DAR-2011-00048 | 2,011 | 26 | 25-34 | Male | Kaposi sarcoma | Lymphoma | Grade IV | Clinical only | Lost | 1 | high_burden |
TZ-DAR-2010-00049 | 2,010 | 58 | 55-64 | Male | Liver | Adenocarcinoma | Grade I | Microscopy | Dead | 3.4 | high_burden |
TZ-DAR-2017-00050 | 2,017 | 63 | 55-64 | Female | Other | Squamous cell carcinoma | Grade IV | DCO | Alive | 51.6 | high_burden |
TZ-DAR-2008-00051 | 2,008 | 71 | 65-74 | Female | Cervix uteri | Adenocarcinoma | Grade I | Microscopy | Alive | 11.3 | high_burden |
TZ-DAR-2009-00052 | 2,009 | 66 | 65-74 | Male | Hodgkin lymphoma | Squamous cell carcinoma | Grade II | Microscopy | Dead | 5.5 | high_burden |
TZ-DAR-2018-00053 | 2,018 | 52 | 45-54 | Female | Other | Sarcoma (incl KS) | Grade II | Microscopy | Alive | 2.6 | high_burden |
TZ-DAR-2008-00054 | 2,008 | 84 | 75+ | Male | Other | Squamous cell carcinoma | Grade II | Microscopy | Dead | 44.6 | high_burden |
TZ-DAR-2008-00055 | 2,008 | 43 | 35-44 | Male | Liver | Non-keratinizing | Grade II | Microscopy | Dead | 0.1 | high_burden |
TZ-DAR-2011-00056 | 2,011 | 70 | 65-74 | Female | Other | Adenocarcinoma | Grade I | Microscopy | Alive | 0.7 | high_burden |
TZ-DAR-2009-00057 | 2,009 | 51 | 45-54 | Female | Other | Sarcoma (incl KS) | Grade IV | Microscopy | Dead | 7 | high_burden |
TZ-DAR-2016-00058 | 2,016 | 39 | 35-44 | Male | Kaposi sarcoma | Leukemia | Grade II | Imaging + clinical | Dead | 31.3 | high_burden |
TZ-DAR-2009-00059 | 2,009 | 27 | 25-34 | Male | Leukemia | Non-keratinizing | Grade II | Microscopy | Alive | 7.6 | high_burden |
TZ-DAR-2011-00060 | 2,011 | 90 | 75+ | Female | Breast | Adenocarcinoma | Grade IV | Microscopy | Dead | 22.7 | high_burden |
TZ-DAR-2017-00061 | 2,017 | 47 | 45-54 | Male | Non-Hodgkin lymphoma | Adenocarcinoma | Grade III | Imaging + clinical | Alive | 33.7 | high_burden |
TZ-DAR-2011-00062 | 2,011 | 36 | 35-44 | Female | Thyroid | Squamous cell carcinoma | Unknown | Microscopy | Dead | 66.6 | high_burden |
TZ-DAR-2012-00063 | 2,012 | 59 | 55-64 | Male | Oesophagus | Squamous cell carcinoma | Grade I | Microscopy | Dead | 70.6 | high_burden |
TZ-DAR-2018-00064 | 2,018 | 63 | 55-64 | Female | Cervix uteri | Non-keratinizing | Grade II | DCO | Dead | 3.8 | high_burden |
TZ-DAR-2017-00065 | 2,017 | 63 | 55-64 | Female | Cervix uteri | Lymphoma | Grade III | Microscopy | Alive | 3.9 | high_burden |
TZ-DAR-2015-00066 | 2,015 | 10 | 0-14 | Female | Breast | Adenocarcinoma | Grade III | Microscopy | Alive | 22.5 | high_burden |
TZ-DAR-2012-00067 | 2,012 | 66 | 65-74 | Male | Prostate | Adenocarcinoma | Unknown | Microscopy | Alive | 10 | high_burden |
TZ-DAR-2017-00068 | 2,017 | 56 | 55-64 | Male | Other | Non-keratinizing | Grade II | Microscopy | Alive | 5.5 | high_burden |
TZ-DAR-2018-00069 | 2,018 | 69 | 65-74 | Male | Prostate | Adenocarcinoma | Grade II | Microscopy | Dead | 14 | high_burden |
TZ-DAR-2015-00070 | 2,015 | 37 | 35-44 | Female | Cervix uteri | Other | Grade I | Microscopy | Alive | 40.1 | high_burden |
TZ-DAR-2008-00071 | 2,008 | 43 | 35-44 | Male | Other | Squamous cell carcinoma | Unknown | Clinical only | Dead | 35.9 | high_burden |
TZ-DAR-2008-00072 | 2,008 | 35 | 35-44 | Female | Cervix uteri | Squamous cell carcinoma | Grade IV | Clinical only | Alive | 28.2 | high_burden |
TZ-DAR-2017-00073 | 2,017 | 36 | 35-44 | Male | Leukemia | Sarcoma (incl KS) | Unknown | Microscopy | Lost | 49.6 | high_burden |
TZ-DAR-2014-00074 | 2,014 | 58 | 55-64 | Female | Thyroid | Squamous cell carcinoma | Grade IV | Microscopy | Dead | 5.7 | high_burden |
TZ-DAR-2013-00075 | 2,013 | 45 | 45-54 | Male | Kaposi sarcoma | Sarcoma (incl KS) | Grade II | Clinical only | Dead | 12.5 | high_burden |
TZ-DAR-2016-00076 | 2,016 | 38 | 35-44 | Male | Non-Hodgkin lymphoma | Adenocarcinoma | Grade I | Microscopy | Dead | 4.2 | high_burden |
TZ-DAR-2009-00077 | 2,009 | 56 | 55-64 | Female | Other | Adenocarcinoma | Grade III | Microscopy | Dead | 5.7 | high_burden |
TZ-DAR-2017-00078 | 2,017 | 37 | 35-44 | Female | Cervix uteri | Non-keratinizing | Grade II | Microscopy | Dead | 23.6 | high_burden |
TZ-DAR-2018-00079 | 2,018 | 78 | 75+ | Male | Stomach | Leukemia | Grade III | Microscopy | Lost | 17 | high_burden |
TZ-DAR-2017-00080 | 2,017 | 27 | 25-34 | Male | Stomach | Sarcoma (incl KS) | Grade II | Microscopy | Dead | 23.9 | high_burden |
TZ-DAR-2016-00081 | 2,016 | 58 | 55-64 | Female | Cervix uteri | Squamous cell carcinoma | Grade II | Imaging + clinical | Dead | 44.5 | high_burden |
TZ-DAR-2008-00082 | 2,008 | 94 | 75+ | Female | Thyroid | Adenocarcinoma | Grade III | DCO | Dead | 25.1 | high_burden |
TZ-DAR-2014-00083 | 2,014 | 84 | 75+ | Male | Kaposi sarcoma | Squamous cell carcinoma | Grade III | Microscopy | Alive | 36.7 | high_burden |
TZ-DAR-2012-00084 | 2,012 | 27 | 25-34 | Male | Kaposi sarcoma | Squamous cell carcinoma | Grade II | Microscopy | Alive | 48 | high_burden |
TZ-DAR-2018-00085 | 2,018 | 62 | 55-64 | Female | Other | Adenocarcinoma | Grade II | Microscopy | Alive | 10.2 | high_burden |
TZ-DAR-2012-00086 | 2,012 | 46 | 45-54 | Female | Breast | Lymphoma | Unknown | Microscopy | Alive | 18.2 | high_burden |
TZ-DAR-2008-00087 | 2,008 | 61 | 55-64 | Female | Breast | Squamous cell carcinoma | Grade III | Microscopy | Lost | 13.3 | high_burden |
TZ-DAR-2015-00088 | 2,015 | 70 | 65-74 | Male | Prostate | Lymphoma | Unknown | Microscopy | Dead | 7.9 | high_burden |
TZ-DAR-2008-00089 | 2,008 | 41 | 35-44 | Female | Breast | Adenocarcinoma | Grade II | Clinical only | Dead | 4.3 | high_burden |
TZ-DAR-2012-00090 | 2,012 | 48 | 45-54 | Female | Other | Adenocarcinoma | Grade IV | Microscopy | Alive | 2.1 | high_burden |
TZ-DAR-2008-00091 | 2,008 | 29 | 25-34 | Male | Oesophagus | Adenocarcinoma | Grade II | Microscopy | Dead | 2.5 | high_burden |
TZ-DAR-2015-00092 | 2,015 | 40 | 35-44 | Female | Breast | Non-keratinizing | Unknown | Microscopy | Dead | 5.3 | high_burden |
TZ-DAR-2016-00093 | 2,016 | 63 | 55-64 | Male | Non-Hodgkin lymphoma | Adenocarcinoma | Grade III | Microscopy | Alive | 56.5 | high_burden |
TZ-DAR-2013-00094 | 2,013 | 66 | 65-74 | Male | Non-Hodgkin lymphoma | Non-keratinizing | Grade I | Clinical only | Alive | 14.9 | high_burden |
TZ-DAR-2010-00095 | 2,010 | 42 | 35-44 | Male | Kaposi sarcoma | Squamous cell carcinoma | Grade II | Imaging + clinical | Dead | 2.4 | high_burden |
TZ-DAR-2017-00096 | 2,017 | 5 | 0-14 | Female | Cervix uteri | Non-keratinizing | Grade II | Microscopy | Alive | 67.3 | high_burden |
TZ-DAR-2016-00097 | 2,016 | 28 | 25-34 | Female | Other | Other | Grade IV | Microscopy | Dead | 12.6 | high_burden |
TZ-DAR-2014-00098 | 2,014 | 37 | 35-44 | Female | Other | Squamous cell carcinoma | Unknown | Microscopy | Alive | 6.9 | high_burden |
TZ-DAR-2018-00099 | 2,018 | 56 | 55-64 | Female | Other | Squamous cell carcinoma | Grade IV | Microscopy | Dead | 6 | high_burden |
TZ-DAR-2010-00100 | 2,010 | 33 | 25-34 | Female | Cervix uteri | Adenocarcinoma | Grade I | DCO | Dead | 32 | high_burden |
Tanzania Cancer Registry - Dar es Salaam | Africa (Electric Sheep Africa metadata inventory)
Size category: 10K<n<100K - Formats: csv - Sector: health - Engineered by Electric Sheep Africa
TL;DR
This dataset is part of the Electric Sheep Africa catalog on Hugging Face. It is indexed for African data discovery with standardized metadata, loading guidance, provenance notes, and analyst-oriented context.
What This Dataset Covers
Health datasets help researchers examine disease burden, service delivery, risk factors, outcomes, and public-health program performance.
Dataset context from the existing Hugging Face card: ⚠️ Synthetic dataset — Parameterized from published SSA literature, not real observations. Not suitable for empirical analysis or policy inference. Tanzania Cancer Registry - Dar es Salaam Abstract This synthetic dataset represents population-based cancer registry data for dar es salaam and is designed to address the significant data gap in cancer research for sub-Saharan Africa. The dataset contains 2,800-4,200 per scenario records per scenario with key epidemiological… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-tanzania-cancer-dar-tanzania.
Dataset Profile
| Field | Value |
|---|---|
| Hugging Face repo | electricsheepafrica/africa-synth-cancer-tanzania-cancer-dar-tanzania |
| Sector | health |
| Topic tags | cancer, oncology, synthetic, healthcare, sub-saharan-africa, tanzania |
| Modalities | tabular, text |
| Formats | csv |
| Size category | 10K<n<100K |
| Countries | Tanzania |
| ISO3 coverage | TZA |
| Last modified on HF | 2026-04-14 22:47:46+00:00 |
| Inventory snapshot | 2026-07-16T16:00:34Z |
How To Read This Dataset
- Start from the repository files and the dataset viewer when available.
- Treat the README context as a fast orientation layer; confirm variable definitions and units in the data files before modeling.
- Use explicit country columns when present. When geography is only implied by the title or source metadata, document that assumption in downstream analysis.
- Preserve missing values until you have a defensible imputation rule.
Usage
from datasets import load_dataset
ds = load_dataset("electricsheepafrica/africa-synth-cancer-tanzania-cancer-dar-tanzania")
print(ds)
split_name = next(iter(ds))
table = ds[split_name]
print(table.features)
print(table[:3])
Convert To Pandas When Tabular
from datasets import Dataset
first_split = ds[next(iter(ds))]
if isinstance(first_split, Dataset):
df = first_split.to_pandas()
print(df.head())
Data Quality Notes
- This card was standardized from the Electric Sheep Africa Hugging Face metadata inventory.
- Exact schema, row counts, and source files should be inspected in the repository data files.
- Metadata gaps from the inventory: upstream_publisher.
- Do not infer policy meaning from labels alone; confirm definitions, units, and methods in the source material.
Source And Provenance
- Source context: Electric Sheep Africa metadata inventory
- Publisher/source attribution: Public dataset metadata
- License: CC BY 4.0
- Hugging Face URL: https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-tanzania-cancer-dar-tanzania
- Inventory retrieved at:
2026-07-16T16:00:34Z
Suggested Analyses
- Inspect schema and missingness before modeling.
- Profile variables by geography, time, and subgroup columns where present.
- Join with other Electric Sheep Africa datasets using explicit country, year, and indicator fields when available.
- Build reproducible notebooks that cite both the original source context and the Electric Sheep Africa Hugging Face repo.
Citation
@misc{electric_sheep_africa_africa_synth_cancer_tanzania_cancer_dar_tanzania_2026,
title = {Tanzania Cancer Registry - Dar es Salaam | Africa (Electric Sheep Africa metadata inventory)},
author = {Public dataset metadata},
year = {2026},
url = {https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-tanzania-cancer-dar-tanzania},
publisher = {Hugging Face Datasets, engineered by Electric Sheep Africa},
howpublished = {\url{https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-tanzania-cancer-dar-tanzania}}
}
License
Released under CC BY 4.0.
Original source rights remain with the original publisher or data provider. Electric Sheep Africa engineering standardizes discovery metadata, documentation, and usage guidance for analysis on Hugging Face.
About Electric Sheep Africa
Electric Sheep Africa publishes ML-ready African public datasets on Hugging Face.
Provenance: metadata-backed README standardized 2026-08-12 by the Electric Sheep Africa README system. Inventory source: catalog/esa_metadata_inventory/master_metadata.jsonl.
- Downloads last month
- 43